Seqirus USA Inc #70461012203 FLUAD™ 2022 - 2023 Flu Vaccine, Adjuvanted 45 mcg / 0.5 mL Indicated for People 65 Years of Age and Above Prefilled Syringe 0.5 mL FLUAD 2023, QUAD SYR 0.5ML (10DOSE/BX) Features Fluad is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine FLUAD is approved for use in persons 65 years of age and older Each 0.5 mL dose contains at least 15 mcg of hemagglutinin (HA) from each of the following three influenza strains recommended for the 2022 - 2023 influenza season; A/Brisbane/02/2018 IVR-190 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Kansas/14/2017 X-327 (an A/Kansas/14/2017 (H3N2)-like virus), B/Maryland/15/2016 (a B/Colorado/06/2017-like virus) FLUAD also contains MF59C.1 adjuvant (MF59®), a squalene based oil-in-water emulsion Manufacturer # 70461012203 Brand FLUAD™ 202 - 2023 Manufacturer Seqirus USA Inc Country of Origin United States Application Flu Vaccine, Adjuvanted Container Type Prefilled Syringe Dosage Form Injection NDC Number 70461012203 Storage Requirements Requires Refrigeration Strength 45 mcg / 0.5 mL Type Intramuscular UNSPSC Code 51201608 User Indicated For People 65 Years of Age and Above Volume 0.5 mL
Size: 5mL
More Information
